Kevin Harrington: FDA Approval Marks a Major Breakthrough for RP1

Oncodaily

AIMode News Desk · curated summary

August 12, 20261 min readHealth

Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.

Related coverage: Kevin Harrington: FDA Approval Marks a Major Breakthrough for RP1 Oncodaily

About this story

This story was aggregated from Oncodaily. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.

Read the full story →

More in Health

Health

How CAR T cells are being engineered to target tumour's 'soft spot'

Related coverage: How CAR T cells are being engineered to target tumour's 'soft spot' Drug Target Review

Drug Target Review · 1 hour ago

Health

Deadly disease outbreak kills 2,000 as experts reveal what Americans should know

Related coverage: Deadly disease outbreak kills 2,000 as experts reveal what Americans should know Fox News Congo Ebola death toll tops 2,000 as outbreak becomes fastest spreading on record CBS News Ebola virus behind massive outbreak in DRC could be mutating, officials say The Guardian Africa CDC and WHO call for urgent, community-led action to contain Ebola in the DRC World Health Organization (WHO) Congo says number of confirmed Ebola cases rises to 4,449 Reuters

Fox News · 1 hour ago

Health

Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research

Related coverage: Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research PR Newswire

PR Newswire · 1 hour ago

Health

mRNA immunotherapy developed by UMass Chan scientists eliminates pancreatic tumors in mice

Related coverage: mRNA immunotherapy developed by UMass Chan scientists eliminates pancreatic tumors in mice UMass Chan Medical School

UMass Chan Medical School · 8 hours ago